FDA OKs New Gene Therapy for Debilitating Skin Condition

(MedPage Today) -- The FDA approved prademagene zamikeracel (Zevaskyn) for treating adults and children with the blistering wounds caused by recessive dystrophic epidermolysis bullosa (RDEB), Abeona Therapeutics announced on Tuesday.
Patients...